New heart stent put to the test in 1,000 patients
NCT ID NCT06177743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new heart stent called Coroflex ISAR NEO in 1,000 people with narrowed heart arteries. The goal is to see how safe and effective it is compared to other stents in everyday medical practice. Researchers will track major heart problems like death, heart attack, or the need for another procedure over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Coroflex ISAR NEO stent (a drug-coated mesh tube placed in heart arteries to keep them open)
What this could lead to
If successful, this could confirm that the Coroflex ISAR NEO stent is a safe and effective option for treating blocked heart arteries in everyday practice.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. Stents carry risks like blood clots or re-narrowing, and long-term outcomes are still being tracked.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center
RECRUITINGSeoul, Songpa-gu, 138-736, South Korea
Contact
Contact
-
Bucheon Sejong Hospital
RECRUITINGBucheon-si, South Korea
Contact
Contact
-
Chonnam National University Hospital
NOT_YET_RECRUITINGGwangju, South Korea
Contact
Contact
-
Inje University Ilsan Paik Hospital
NOT_YET_RECRUITINGIlsan, South Korea
Contact
Contact
-
Myongji Hospital
RECRUITINGIlsan, South Korea
Contact
Contact
-
Sejong Chungnam National University Hospital
RECRUITINGSejong, South Korea
Contact
Contact
-
Seoul National University Boramae Medical Center
NOT_YET_RECRUITINGSeoul, South Korea
Contact
Contact
-
The Catholic Univ. of Korea BUCHEON ST.Mary's hospital
RECRUITINGBucheon-si, South Korea
Contact
Contact
-
The Catholic university of Korea, ST. Vincent's Hospital
RECRUITINGSuwon, South Korea
Contact
Contact
-
Uijeongbu Eulji Medical Center
WITHDRAWNUijeongbu-si, South Korea
-
Veterans Hospital
RECRUITINGDaegu, South Korea
Contact
Contact